Net loss per share
9 Months Ended
Dec. 31, 2019
Net loss per share  
Net loss per share

10.         Net loss per share

Basic and diluted net loss per share attributable to common stockholders was calculated as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

December 31, 

 

December 31, 

 

    

2019

    

2018

    

2019

    

2018

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stockholders

 

$

(16,189)

 

$

(7,673)

 

$

(36,836)

 

$

(24,178)

Denominator:

 

 

  

 

 

  

 

 

  

 

 

  

Weighted average common shares outstanding, basic and diluted

 

 

34,877,944

 

 

31,577,313

 

 

32,742,148

 

 

20,433,580

Net loss per share attributable to common stockholders, basic and diluted

 

$

(0.46)

 

$

(0.24)

 

$

(1.13)

 

$

(1.18)

 

Included within weighted average common shares outstanding are common shares issuable upon the exercise of the pre-funded warrants as the warrants are exercisable at any time for nominal consideration, and as such, the shares are considered outstanding for the purpose of calculating  basic and diluted net loss per share attributable to common stockholders.

The Company’s potentially dilutive securities, which include stock options  and warrants to purchase shares of series seed preferred stock, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Common A stock has been excluded from the computation of diluted net loss per share because the shares have nominal economic participation rights. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti‑dilutive effect:

 

 

 

 

 

 

 

 

Three and Nine Months Ended 

 

 

December 31, 

 

    

2019

    

2018

Options to purchase common stock

 

4,916,402

 

3,673,535

Warrants to purchase convertible preferred stock (as converted to common stock)

 

497,344

 

497,344

 

 

5,413,746

 

4,170,879